Published June, 2021
By Anne Johnson, Mark Harvey, Claire Delduca and Reg Morris
Publisher: Taylor & Francis (Routledge)
Rating:
Availability: Available
By Anne Johnson, Mark Harvey, Claire Delduca and Reg Morris
Publisher: Taylor & Francis (Routledge)
Rating:
Availability: Available
Combining this transdiagnostic approach with the lived experiences of people with cancer, the book covers the range of psychological symptoms and conditions as a result of cancer.
Hardback
€166.40
Published June, 2021
By Nobutoshi Ando
Publisher: Springer (Springer Verlag, Singapore)
Rating: 1.00
Availability: Available
By Nobutoshi Ando
Publisher: Springer (Springer Verlag, Singapore)
Rating: 1.00
Availability: Available
Paperback / softback
€127.99
Published June, 2021
By Francis J. Hornicek
Publisher: Springer (Springer Nature Switzerland AG)
Rating:
Availability: Available
By Francis J. Hornicek
Publisher: Springer (Springer Nature Switzerland AG)
Rating:
Availability: Available
Paperback / softback
€83.19
Published June, 2021
By Jinsil Seong
Publisher: Springer (Springer Verlag, Singapore)
Rating: 1.00
Availability: Available
By Jinsil Seong
Publisher: Springer (Springer Verlag, Singapore)
Rating: 1.00
Availability: Available
The radiotherapy strategies appropriate in different patient groups are then fully described, covering the use of ablative, adjuvant, neoadjuvant, and definitive radiotherapy, radiotherapy as a bridge to liver transplantation, and palliative radiotherapy.
Hardback
€153.59
Published June, 2021
By Kamal Dua and Pawan K. Maurya
Publisher: Springer (Springer Verlag, Singapore)
Rating: 1.00
Availability: Available
By Kamal Dua and Pawan K. Maurya
Publisher: Springer (Springer Verlag, Singapore)
Rating: 1.00
Availability: Available
Paperback / softback
€127.99
Published June, 2021
By Ganji Purnachandra Nagaraju, Dhananjay Shukla and Naveen Kumar Vishvakarma
Publisher: Springer (Springer Nature Switzerland AG)
Rating:
Availability: Available
By Ganji Purnachandra Nagaraju, Dhananjay Shukla and Naveen Kumar Vishvakarma
Publisher: Springer (Springer Nature Switzerland AG)
Rating:
Availability: Available
Despite advances in therapeutic strategies, the five-year survival rate for CRC patients has remained the same over time due to the fact that patients are often diagnosed in advanced metastatic stages. Each volume focuses on different novel therapeutic advances, biomarkers, and identifies therapeutic targets for treatment.
Hardback
€204.79
Published June, 2021
By Ludmilla Thome Domingos Chinen
Publisher: Springer (Springer Nature Switzerland AG)
Rating:
Availability: Available
By Ludmilla Thome Domingos Chinen
Publisher: Springer (Springer Nature Switzerland AG)
Rating:
Availability: Available
This book provides a wealth of images and extensive information on circulating tumor cells (CTCs) and other cells usually observed in blood from patients with cancer, such as giant macrophages, and circulating tumor microemboli (CTM).
The field of "liquid biopsy" began with the analysis of CTCs in the early 2000s.
Hardback
€166.39
Published June, 2021
By Temel Tirkes
Publisher: Springer (Springer Nature Switzerland AG)
Rating:
Availability: Available
By Temel Tirkes
Publisher: Springer (Springer Nature Switzerland AG)
Rating:
Availability: Available
Paperback / softback
€115.19
Published June, 2021
By Martin Goette and Karin Forsberg-Nilsson
Publisher: Springer (Springer Nature Switzerland AG)
Rating:
Availability: Available
By Martin Goette and Karin Forsberg-Nilsson
Publisher: Springer (Springer Nature Switzerland AG)
Rating:
Availability: Available
Since proteoglycans modulate cell adhesion and migration they are important organizers of the extracellular matrix within the proper stem cell niche.
Hardback
€179.19
Published June, 2021
By Ganji Purnachandra Nagaraju, Dhananjay Shukla and Naveen Kumar Vishvakarma
Publisher: Springer (Springer Nature Switzerland AG)
Rating:
Availability: Available
By Ganji Purnachandra Nagaraju, Dhananjay Shukla and Naveen Kumar Vishvakarma
Publisher: Springer (Springer Nature Switzerland AG)
Rating:
Availability: Available
Despite advances in therapeutic strategies, the five-year survival rate for CRC patients has remained the same over time due to the fact that patients are often diagnosed in advanced metastatic stages. Each volume focuses on different novel therapeutic advances, biomarkers, and identifies therapeutic targets for treatment.
Hardback
€179.19